Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Report

Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 13, 2022
  • PAGES：212
  • REPORT CODE：GMM1369535
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Neuromyelitis Optica Spectrum Disorder (NMOSD) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Opexa Therapeutics

    • Cour Pharmaceutical

    • Nihon Pharmaceutical

    • TG Therapeutics

    • Alexion Pharmaceuticals

    • Bio-Thera Solutions

    • Boston Pharmaceuticals

    • F Hoffmann-La Roche Ltd

    • Bionure

    • Harbour BioMed

    • RemeGen

    • Lundbeck

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Intravenous

    • Oral

    • Subcutaneous

    • Others

    Application:

    • Hospital

    • Clinic

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Overview

      • 1.1.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Scope and Market Segments

      • 1.1.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Characteristics

      • 1.1.3 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Intravenous

      • 1.2.2 Oral

      • 1.2.3 Subcutaneous

      • 1.2.4 Others

    • 1.3 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry PEST Analysis

    • 2.3 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry

    Chapter 3 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Manufacturer

    • 3.1 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Top 3 Players

    Chapter 4 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Type (2017-2028)

    • 4.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Trend, by Type

    • 4.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Price Trend, by Type (2017-2028)

    • 4.3 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis

    • 7.1 North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Type

    • 7.2 North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Application

    • 7.3 North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis and Forecast, by Country

      • 7.3.1 United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis

    • 8.1 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Type

    • 8.2 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Application

    • 8.3 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis

    • 9.1 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Type

    • 9.2 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Application

    • 9.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis and Forecast, by Country

      • 9.3.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis

    • 10.1 Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Type

    • 10.2 Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Application

    • 10.3 Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Company Profiles

      • 11.1 Opexa Therapeutics

        • 11.1.1 Opexa Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.1.3 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Cour Pharmaceutical

        • 11.2.1 Cour Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.2.3 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Nihon Pharmaceutical

        • 11.3.1 Nihon Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.3.3 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 TG Therapeutics

        • 11.4.1 TG Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.4.3 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Alexion Pharmaceuticals

        • 11.5.1 Alexion Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.5.3 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Bio-Thera Solutions

        • 11.6.1 Bio-Thera Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.6.3 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Boston Pharmaceuticals

        • 11.7.1 Boston Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.7.3 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 F Hoffmann-La Roche Ltd

        • 11.8.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 F Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.8.3 F Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Bionure

        • 11.9.1 Bionure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.9.3 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Harbour BioMed

        • 11.10.1 Harbour BioMed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.10.3 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 RemeGen

        • 11.11.1 RemeGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.11.3 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Lundbeck

        • 11.12.1 Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Profiles, Application and Specification

        • 11.12.3 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Investment Prospect and Risk Assessment

    • 12.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Production Value and Growth Rate (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Production Value and Growth Rate (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Intravenous (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Subcutaneous (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Share, by Manufacturer in 2021

    • Figure Global and China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Share, by Manufacturer in 2022

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Type (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value, by Type (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value Share, by Type (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Price Trend, by Type (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Type (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value, by Type (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value Share, by Type (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Price Trend, by Type (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Application (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value, by Application (2017-2028)

    • Table Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value Share, by Application (2017-2028)

    • Figure Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value Share, by Application (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Application (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value, by Application (2017-2028)

    • Table China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value Share, by Application (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value Share, by Application (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Production, Import, Consumption and Export (2017-2022)

    • Table North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Type (2017-2028)

    • Table North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Figure North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Table North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Application (2017-2028)

    • Table North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Table Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Type (2017-2028)

    • Table Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Table Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Application (2017-2028)

    • Table Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure France Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure France Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Table APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Type (2017-2028)

    • Table APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Table APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Application (2017-2028)

    • Table APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure China Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure India Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure India Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Value and Growth Rate (2017-2028)

    • Table Opexa Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Opexa Therapeutics Product Profiles, Application and Specification

    • Table Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cour Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cour Pharmaceutical Product Profiles, Application and Specification

    • Table Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nihon Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nihon Pharmaceutical Product Profiles, Application and Specification

    • Table Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TG Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TG Therapeutics Product Profiles, Application and Specification

    • Table TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alexion Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alexion Pharmaceuticals Product Profiles, Application and Specification

    • Table Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bio-Thera Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bio-Thera Solutions Product Profiles, Application and Specification

    • Table Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boston Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boston Pharmaceuticals Product Profiles, Application and Specification

    • Table Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bionure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bionure Product Profiles, Application and Specification

    • Table Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Harbour BioMed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Harbour BioMed Product Profiles, Application and Specification

    • Table Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RemeGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RemeGen Product Profiles, Application and Specification

    • Table RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lundbeck Product Profiles, Application and Specification

    • Table Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US